Patent details

Basic Information

Publication number:

EP2943181

PCT Application Number:

GB2014050052

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP147001143

PCT Publication Number:

WO2014108685

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PHARMACEUTICAL COMPOSITIONS

French Title of Invention:

COMPOSITIONS PHARMACEUTIQUES

German Title of Invention:

PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

SPC Number:

Dates

Filing date:

09/01/2014

Grant date:

10/04/2019

EP Publication Date:

18/11/2015

PCT Publication Date:

17/07/2014

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/04/2019

EP B1 Publication Date:

10/04/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/01/2020

Expiration date:

09/01/2034

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/04/2019

 

 

Name:

Kalvista Pharmaceuticals Limited

Address:

Porton Science Park Bybrook Road, Porton Down Wiltshire SP4 0BF, United Kingdom (GB)

Inventor

1

Name:

GWOZDZ, Garry Thomas

Address:

United States (US)

2

Name:

COOK, Gary Paul

Address:

United States (US)

3

Name:

LASLO, Theodore Patrick

Address:

United States (US)

Priority

1

Priority Number:

201361750568 P

Priority Date:

09/01/2013

Priority Country:

United States (US)

2

Priority Number:

201301895

Priority Date:

04/02/2013

Priority Country:

United Kingdom (GB)

Classification

IPC classification:

A61K 9/00; A61K 9/10; A61K 31/00; A61K 47/26; A61K 47/18;

Publication

European Patent Bulletin

Issue number:

201915

Publication date:

10/04/2019

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages